EP1931806A4 - Activation de la pkr par reaction en chaine d'hybridation - Google Patents

Activation de la pkr par reaction en chaine d'hybridation

Info

Publication number
EP1931806A4
EP1931806A4 EP06836249A EP06836249A EP1931806A4 EP 1931806 A4 EP1931806 A4 EP 1931806A4 EP 06836249 A EP06836249 A EP 06836249A EP 06836249 A EP06836249 A EP 06836249A EP 1931806 A4 EP1931806 A4 EP 1931806A4
Authority
EP
European Patent Office
Prior art keywords
pkr
activation
rna
hybridization chain
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP06836249A
Other languages
German (de)
English (en)
Other versions
EP1931806A2 (fr
EP1931806B1 (fr
Inventor
Robert Dirks
Niles A Pierce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Institute of Technology
Original Assignee
California Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Institute of Technology filed Critical California Institute of Technology
Publication of EP1931806A2 publication Critical patent/EP1931806A2/fr
Publication of EP1931806A4 publication Critical patent/EP1931806A4/fr
Application granted granted Critical
Publication of EP1931806B1 publication Critical patent/EP1931806B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
EP06836249A 2005-10-07 2006-10-06 Activation de la pkr par reaction en chaine d'hybridation Not-in-force EP1931806B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72501105P 2005-10-07 2005-10-07
PCT/US2006/039571 WO2007044727A2 (fr) 2005-10-07 2006-10-06 Activation de la pkr par reaction en chaine d'hybridation

Publications (3)

Publication Number Publication Date
EP1931806A2 EP1931806A2 (fr) 2008-06-18
EP1931806A4 true EP1931806A4 (fr) 2010-05-26
EP1931806B1 EP1931806B1 (fr) 2011-10-05

Family

ID=37943474

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06836249A Not-in-force EP1931806B1 (fr) 2005-10-07 2006-10-06 Activation de la pkr par reaction en chaine d'hybridation

Country Status (4)

Country Link
US (2) US7960357B2 (fr)
EP (1) EP1931806B1 (fr)
AT (1) ATE526975T1 (fr)
WO (1) WO2007044727A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005023426D1 (de) * 2004-03-25 2010-10-21 California Inst Of Techn Hybridisierungskettenreaktion
US7727721B2 (en) 2005-03-08 2010-06-01 California Institute Of Technology Hybridization chain reaction amplification for in situ imaging
US7960357B2 (en) 2005-10-07 2011-06-14 California Institute Of Technology PKR activation via hybridization chain reaction
US8778846B2 (en) * 2006-12-04 2014-07-15 General Electric Company Composition, device and associated method
WO2008106658A2 (fr) * 2007-03-01 2008-09-04 California Institute Of Technology Arni déclenché
US9217151B2 (en) 2007-05-16 2015-12-22 California Institute Of Technology Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
US8497364B2 (en) 2008-02-27 2013-07-30 California Institute Of Technology Triggered RNAi
US20100021904A1 (en) * 2008-05-21 2010-01-28 Pierce Niles A Shielded cross-linking probes
US20100021901A1 (en) * 2008-05-22 2010-01-28 Peng Yin Compositions and methods for detecting analytes
US8241854B2 (en) 2008-05-22 2012-08-14 California Institute Of Technology Triggered RNAi
RU2529804C2 (ru) * 2008-10-23 2014-09-27 Конинклейке Филипс Электроникс, Н.В. Молекулярная визуализация
CN101756151B (zh) * 2008-12-24 2012-12-12 安琪酵母股份有限公司 一种高谷氨酸酵母抽提物及其制备方法
JP2009159990A (ja) * 2009-04-21 2009-07-23 Sanei Gen Ffi Inc 高栄養食
US8658780B2 (en) * 2010-05-18 2014-02-25 California Institute Of Technology Triggered covalent probes for imaging and silencing genetic expression
US9834439B2 (en) 2010-07-20 2017-12-05 California Institute Of Technology Biomolecular self-assembly
US8877438B2 (en) 2010-07-20 2014-11-04 California Institute Of Technology Self-assembled polynucleotide structure
US8962241B2 (en) 2010-07-20 2015-02-24 California Institute Of Technology Triggered molecular geometry based bioimaging probes
DE102012203964B3 (de) * 2012-03-14 2013-02-28 GNA Biosolultions GmbH Verfahren und Kit zur Detektion von Nukleinsäuren
US9856472B2 (en) 2013-07-01 2018-01-02 California Institute Of Technology Small conditional RNAs
GB201401885D0 (en) 2014-02-04 2014-03-19 Olink Ab Proximity assay with detection based on hybridisation chain reaction (HCR)
WO2018009463A2 (fr) 2016-07-05 2018-01-11 California Institute Of Technology Réaction en chaîne d'hybridation d'initiateurs fractionnaire
WO2018044939A1 (fr) 2016-08-30 2018-03-08 California Institute Of Technology Immunohistochimie par réaction en chaîne d'hybridation
AU2018272848B2 (en) * 2017-05-23 2022-03-31 Rutgers, The State University Of New Jersey Target mediated
US12054711B2 (en) 2017-07-14 2024-08-06 City Of Hope Meta-stable oligonucleotides junctions for delivery of therapeutics
WO2019033079A1 (fr) 2017-08-10 2019-02-14 City Of Hope Arnsi conditionnels et leurs utilisations dans le traitement de l'hypertrophie cardiaque
CN110286216B (zh) * 2019-05-16 2021-10-15 中国科学院武汉物理与数学研究所 一种快速可视化的溶血性大肠杆菌o157：h7检测方法
US11873485B2 (en) 2021-01-26 2024-01-16 California Institute Of Technology Allosteric conditional guide RNAs for cell-selective regulation of CRISPR/Cas
EP4382110A4 (fr) * 2021-08-04 2025-10-29 Univ Tokyo Composition d'acide nucléique en épingle à cheveux
WO2024005045A1 (fr) * 2022-06-28 2024-01-04 国立大学法人東京大学 Composition d'acide nucléique en épingle à cheveux
JPWO2024166539A1 (fr) * 2023-02-07 2024-08-15
US20240336956A1 (en) 2023-04-04 2024-10-10 California Institute Of Technology Ultrasensitive molecular detection via hybridization chain reaction

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031276A1 (fr) * 1997-12-15 1999-06-24 Nexstar Pharmaceuticals, Inc. Detection homogene d'une cible au moyen d'une interaction entre une balise ligand et un ligand d'acide nucleique

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120706A (en) * 1977-09-16 1978-10-17 Harris Corporation Heteroepitaxial deposition of gap on silicon substrates
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
EP0273085A1 (fr) 1986-12-29 1988-07-06 IntraCel Corporation Procédé pour faire entrer des acides nucléiques dans des cellules eucaryotes
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
EP0547142A1 (fr) 1990-08-28 1993-06-23 Epoch Pharmaceuticals, Inc. Synthese sur support solide d'oligonucleotides places en queue en position 3' par l'intermediaire d'une molecule de liaison
US5563256A (en) 1991-05-29 1996-10-08 Merck & Co., Inc. Eimeria tenella 16S rDNA probes
WO1997027214A1 (fr) 1996-01-24 1997-07-31 Third Wave Technologies, Inc. Clivage invasif d'acides nucleiques
US5424413A (en) 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
FI946201A0 (fi) * 1992-07-02 1994-12-30 Hybridon Inc Itsestabiloidut oligonukleotidit terapeuttisina aineina
US5677136A (en) * 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5787104A (en) * 1995-01-19 1998-07-28 Matsushita Electric Industrial Co., Ltd. Semiconductor light emitting element and method for fabricating the same
CA2215162A1 (fr) * 1995-03-23 1996-09-26 Cantab Pharmaceuticals Research Limited Vecteurs d'apport de genes
WO1997005266A1 (fr) * 1995-07-25 1997-02-13 Introgene B.V. Procedes et moyens d'apport cible de genes
US5579793A (en) * 1995-11-15 1996-12-03 Rubbermaid Health Care Products, Inc. Foldable walker
US6361944B1 (en) * 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US5691145A (en) 1996-08-27 1997-11-25 Becton, Dickinson And Company Detection of nucleic acids using G-quartets
US6344317B2 (en) 1996-10-04 2002-02-05 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
ES2375764T3 (es) 1996-11-29 2012-03-06 Third Wave Technologies, Inc. Endonucleasas fen-1, mezclas y procedimientos de escisión.
US6555367B1 (en) * 1997-10-10 2003-04-29 The United States Of America As Represented By The Department Of Health And Human Services Complex of biotinylated viral vector and ligand for targeted gene delivery
GB9721909D0 (en) * 1997-10-17 1997-12-17 Cantab Pharma Res Gene delivery vectors and their uses
US5989823A (en) * 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
US6242246B1 (en) * 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999047180A1 (fr) * 1998-03-20 1999-09-23 Genzyme Corporation Vecteurs adenoviraux chimeres pour apport cible de genes
US6255469B1 (en) 1998-05-06 2001-07-03 New York University Periodic two and three dimensional nucleic acid structures
US6290839B1 (en) 1998-06-23 2001-09-18 Clinical Micro Sensors, Inc. Systems for electrophoretic transport and detection of analytes
JP4646404B2 (ja) * 1998-07-02 2011-03-09 ジェン−プローブ・インコーポレーテッド 分子トーチ（ｔｏｒｃｈ）
US6899871B2 (en) * 1998-10-01 2005-05-31 University Of Southern California Gene delivery system and methods of use
EP1059357A1 (fr) * 1999-06-09 2000-12-13 Universite Pierre Et Marie Curie Paris Vi Constructions rétrovirales capables de la réplication autonome ou semi-autonome, leur préparation et leurs utilisations pour le transfert de gènes
CA2360342A1 (fr) 1999-12-02 2001-06-07 Molecular Staging Inc. Generation d'adn circulaire a un seul brin a partir de segments lineaires de renaturation automatique
US20050239061A1 (en) 2000-03-01 2005-10-27 Marshall William S Identification and use of effectors and allosteric molecules for the alteration of gene expression
US20040009510A1 (en) 2000-03-06 2004-01-15 Scott Seiwert Allosteric nucleic acid sensor molecules
JP2003535600A (ja) * 2000-06-02 2003-12-02 バイエル コーポレイション インサイチュ分枝ｄｎａハイブリダイゼーションを用いた高感度遺伝子検出および位置決定
CA2451614C (fr) 2001-06-25 2011-01-04 Georgia Tech Research Corporation Sondes doubles d'acide nucleique a transfert d'energie de resonance
US6814832B2 (en) * 2001-07-24 2004-11-09 Seiko Epson Corporation Method for transferring element, method for producing element, integrated circuit, circuit board, electro-optical device, IC card, and electronic appliance
EP1474513A1 (fr) 2002-01-22 2004-11-10 McMaster University Complexes aptameres de signalisation
US20040126773A1 (en) 2002-05-23 2004-07-01 Beske Oren E. Assays with coded sensor particles to sense assay conditions
US20040043386A1 (en) 2002-08-30 2004-03-04 Todd Pray Methods and compositions for functional ubiquitin assays
US20040223953A1 (en) * 2003-03-17 2004-11-11 Hsiang-Fu Kung Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects
US20050112614A1 (en) 2003-05-15 2005-05-26 California Institute Of Technology Self-assembled circuits and circuit patterns
DE602005023426D1 (de) 2004-03-25 2010-10-21 California Inst Of Techn Hybridisierungskettenreaktion
US20060035375A1 (en) 2004-08-16 2006-02-16 Head Jonathan F Method for selectively culturing epithelial or carcinoma cells
EP1815010A2 (fr) 2004-09-24 2007-08-08 Ingeneus Inc. Analyse genomique
ATE514776T1 (de) 2004-10-05 2011-07-15 California Inst Of Techn Aptamer-regulierte nukleinsäuren und verwendungen davon
CA2587010C (fr) 2004-11-08 2017-08-15 Vipergen Aps Sysnthese chimique guidee par acides nucleiques structurels
US20060234261A1 (en) * 2005-03-08 2006-10-19 Pierce Niles A Colorimetric readout of hybridization chain reaction
US7727721B2 (en) * 2005-03-08 2010-06-01 California Institute Of Technology Hybridization chain reaction amplification for in situ imaging
JP4986406B2 (ja) * 2005-03-31 2012-07-25 住友電工デバイス・イノベーション株式会社 半導体装置の製造方法
US7968289B2 (en) 2005-05-03 2011-06-28 Ensemble Therapeutics Corporation Turn over probes and use thereof for nucleic acid detection
US7842793B2 (en) 2005-06-14 2010-11-30 The California Institute Of Technology Methods of making nucleic acid nanostructures
US7960357B2 (en) 2005-10-07 2011-06-14 California Institute Of Technology PKR activation via hybridization chain reaction
GB0607866D0 (en) 2006-04-20 2006-05-31 Isis Innovation Nanostructures
US8445655B2 (en) 2006-06-16 2013-05-21 Cornell Research Foundation, Inc. Functional nucleic acid ligands to fluorescent proteins
WO2008106658A2 (fr) 2007-03-01 2008-09-04 California Institute Of Technology Arni déclenché
CA2686216C (fr) 2007-05-14 2016-04-12 Universidad Nacional Autonoma De Mexico Vm23 et vm24, deux peptides de scorpion qui bloquent les canaux potassiques des lymphocytes t humains (sous-type kv1.3) avec une selectivite elevee et diminuent les reponses dth in vivo dans les rats
US9217151B2 (en) * 2007-05-16 2015-12-22 California Institute Of Technology Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
US8497364B2 (en) 2008-02-27 2013-07-30 California Institute Of Technology Triggered RNAi
US20100021904A1 (en) 2008-05-21 2010-01-28 Pierce Niles A Shielded cross-linking probes
US20100021901A1 (en) 2008-05-22 2010-01-28 Peng Yin Compositions and methods for detecting analytes
US8241854B2 (en) 2008-05-22 2012-08-14 California Institute Of Technology Triggered RNAi
WO2009152492A1 (fr) 2008-06-13 2009-12-17 University Of Connecticut Matériaux d’acide nucléique pour le transfert d’énergie non radiative et procédé de fabrication et d’utilisation
US8642260B2 (en) 2008-10-21 2014-02-04 The Research Foundation Of The City University Of New York Single quantum-dot based aptameric nanosensors
US8478543B2 (en) 2010-04-05 2013-07-02 California Institute Of Technology System and method for nucleic acid sequence design
US8658780B2 (en) 2010-05-18 2014-02-25 California Institute Of Technology Triggered covalent probes for imaging and silencing genetic expression
US8962241B2 (en) 2010-07-20 2015-02-24 California Institute Of Technology Triggered molecular geometry based bioimaging probes
US8877438B2 (en) 2010-07-20 2014-11-04 California Institute Of Technology Self-assembled polynucleotide structure
US9834439B2 (en) 2010-07-20 2017-12-05 California Institute Of Technology Biomolecular self-assembly

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031276A1 (fr) * 1997-12-15 1999-06-24 Nexstar Pharmaceuticals, Inc. Detection homogene d'une cible au moyen d'une interaction entre une balise ligand et un ligand d'acide nucleique

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DIRKS R M ET AL: "Triggered amplification by hybridization chain reaction", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA. (PNAS), NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US LNKD- DOI:10.1073/PNAS.0407024101, vol. 101, no. 43, 26 October 2004 (2004-10-26), pages 15275 - 15278, XP002995798, ISSN: 0027-8424 *
FRIEDRICH ET AL: "A cellular screening assay to test the ability of PKR to induce cell death in mammalian cells", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US LNKD- DOI:10.1016/J.YMTHE.2005.06.442, vol. 12, no. 5, 1 November 2005 (2005-11-01), pages 969 - 975, XP005126660, ISSN: 1525-0016 *
FRIEDRICH I ET AL: "RNA MOLECULES AS ANTI-CANCER AGENTS", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US LNKD- DOI:10.1016/J.SEMCANCER.2004.04.001, vol. 14, no. 4, 1 August 2004 (2004-08-01), pages 223 - 230, XP009049584, ISSN: 1044-579X *
SHIR A ET AL: "Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US LNKD- DOI:10.1038/NBT730, vol. 20, no. 9, 19 August 2002 (2002-08-19), pages 895 - 900, XP002390293, ISSN: 1087-0156 *

Also Published As

Publication number Publication date
US7960357B2 (en) 2011-06-14
US20110313030A1 (en) 2011-12-22
US8962582B2 (en) 2015-02-24
WO2007044727A3 (fr) 2009-05-28
WO2007044727A2 (fr) 2007-04-19
EP1931806A2 (fr) 2008-06-18
ATE526975T1 (de) 2011-10-15
US20070087334A1 (en) 2007-04-19
EP1931806B1 (fr) 2011-10-05

Similar Documents

Publication Publication Date Title
ATE526975T1 (de) Pkr-aktivierung mittels hybridisierungskettenreaktion
WO2005030121A3 (fr) Composes, compositions et procedes
WO2005005599A3 (fr) Modulation de l'expression de la proteine c-reactive
EP1404698A4 (fr) Modulation anti-sens de l'expression de la superoxyde dismutase 1 soluble
WO2004048534A3 (fr) Modulation de l'expression d'une kinase pouvant etre induite par une cytokine
WO2006009765A3 (fr) Procedes d'identification et d'utilisation de composes adaptes au traitement de cellules cancereuses resistantes aux medicaments
WO2006026485A3 (fr) Modulation de l'expression de hif1 beta
WO2007065010A3 (fr) Composes anti-angiogenese
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
WO2004055162A3 (fr) Modulation de l'expression de la lipase endotheliale
EP2363480A3 (fr) Modulation d'expression de récepteur de glucocorticoïde
WO2004009024A3 (fr) Modulation de l'expression de la proteine kinase c-iota
WO2005042552A3 (fr) Modulation de l'expression du sglt2
ATE471954T1 (de) Teilneutralisiertes anionisches (meth)acrylat- copolymer
WO2004094610A3 (fr) Wnt utilise comme facteur pour la myogenese cardiaque
WO2005086804A3 (fr) Modulation de l'expression de ace2
WO2005021727A3 (fr) Ciblage specifique a l'isoforme de variants d'epissure
WO2007062380A3 (fr) MODULATION DE L'EXPRESSION D’eIF4E-BP2
WO2005001031A3 (fr) Modulation de la voie d'interference arn
WO2004047741A3 (fr) Modulation de l'expression de type iap
WO2005006958A8 (fr) Modulation de l'expression de ceacam1
WO2005089123A3 (fr) Traitement anticancereux a base d'adn
WO2004045527A3 (fr) Modulation de l'expression de kinase 6 nima
WO2004048601A3 (fr) Modulation de l'expression de b7h
WO2004043398A3 (fr) Modulation de l'expression du jumonji

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080218

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20090528

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/715 20060101AFI20090609BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100422

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602006024974

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C12Q0001700000

Ipc: A61K0031715000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/715 20060101AFI20110323BHEP

DAX Request for extension of the european patent (deleted)
GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602006024974

Country of ref document: DE

Effective date: 20111208

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20111005

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 526975

Country of ref document: AT

Kind code of ref document: T

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120205

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120206

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120106

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120105

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

26N No opposition filed

Effective date: 20120706

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111006

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602006024974

Country of ref document: DE

Effective date: 20120706

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111005

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20221024

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20221026

Year of fee payment: 17

Ref country code: DE

Payment date: 20221026

Year of fee payment: 17

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602006024974

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20231006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231006

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231031

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240501